Form 8-K - Current report:
SEC Accession No. 0001104659-18-017637
Filing Date
2018-03-15
Accepted
2018-03-15 07:42:59
Documents
5
Period of Report
2018-03-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-8244_18k.htm 8-K 27942
2 EX-99.1 a18-8244_1ex99d1.htm EX-99.1 210759
3 EX-99.2 a18-8244_1ex99d2.htm EX-99.2 13727
4 GRAPHIC g82441moi001.jpg GRAPHIC 3492
5 GRAPHIC g82441mm01i001.jpg GRAPHIC 3492
  Complete submission text file 0001104659-18-017637.txt   263654
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37368 | Film No.: 18691073
SIC: 2836 Biological Products, (No Diagnostic Substances)